Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 5Unknown 3

Sponsor Class

OTHER 78NIH 5NETWORK 4UNKNOWN 3OTHER_GOV 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2CNS 1

Conditions

Stomach Neoplasms 1Meningeal Carcinomatosis 1Esophageal Squamous Cell Carcinoma 1Brain Neoplasms 1

Interventions

Capecitabine 15Paclitaxel 13S 1 (combination) 9apatinib 8Oxaliplatin 8Carboplatin 8Cisplatin 7pyrotinib 6Epirubicin 6Docetaxel 6sintilimab 5camrelizumab 5anlotinib 5Radiotherapy 5Drug Therapy 5130-nm albumin-bound paclitaxel 5nimotuzumab 4nedaplatin 4Vinorelbine 4Temozolomide 4Irinotecan 4Fulvestrant 4Etoposide 4Bevacizumab 4toripalimab 3titanium silicide 3exemestane 3Trastuzumab 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × UNKNOWN × Radiotherapy, Intensity-Modulated × Clear all
NCT04275986 2021-07-07

Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma

ChineseAMS

Phase 2 Unknown
56 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03027544 2017-01-23

TRBM

ChineseAMS

Phase NA Unknown
150 enrolled
CNS

Brain Neoplasms, Meningeal Carcinomatosis

NCT02296658 2014-11-20

A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer

ChineseAMS

Phase 2 Unknown
60 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡